Bionsight @ Takeda COCKPI-T

Bionsight Chosen for Takeda COCKPI-T Collaboration Program

Bionsight has been selected for Takeda’s COCKPI-T Funding Program, through which the company will receive one year of research support and collaboration opportunities.

The COCKPI-T Funding Program is Takeda’s global initiative to accelerate drug discovery innovation. Selected companies gain access to Takeda’s research network, joint project execution, and various funding supports. Bionsight’s selection marks an important step in strengthening its collaborative R&D capabilities and advancing its chemoproteomics-based drug discovery platform.